SEMA3A and rheumatoid arthritis: In patients with systemic lupus erythematosus reduced expression of SEMA3A correlated with inflammation and disease severity [25], and exogenous administration of SEMA3A was associated with markedly reduced articular inflammation in the rheumatoid arthritis mouse model [26].